Novel coronavirus

Drug can significantly block early stages of COVID-19 in engineered human tissues

Trial drug can significantly block early stages of COVID-19 in engineered human tissues

An international team led by University of British Columbia researcher Dr. Josef Penninger has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.

Apr 2, 2020

UBC News spoke with Heidi Tworek about the complicated history of race and disease. Credit: Unsplash

When a virus is the cause, racism is often the symptom

A virus is a virus, but humans have a long history of turning their fear of disease into unwarranted panic about people and places.

Feb 25, 2020